<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS94425</article-id>
<article-id pub-id-type="doi">10.1101/2020.08.31.275719</article-id>
<article-id pub-id-type="archive">PPR208057</article-id>
<article-version article-version-type="publisher-id">2</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but are Not Enriched in Islet Endocrine Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Coate</surname>
<given-names>Katie C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="fn" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cha</surname>
<given-names>Jeeyeon</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="fn" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shrestha</surname>
<given-names>Shristi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Wenliang</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonçalves</surname>
<given-names>Luciana Mateus</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Almaça</surname>
<given-names>Joana</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kapp</surname>
<given-names>Meghan E.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fasolino</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morgan</surname>
<given-names>Ashleigh</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dai</surname>
<given-names>Chunhua</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saunders</surname>
<given-names>Diane C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bottino</surname>
<given-names>Rita</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aramandla</surname>
<given-names>Radhika</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jenkins</surname>
<given-names>Regina</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stein</surname>
<given-names>Roland</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaestner</surname>
<given-names>Klaus H.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vahedi</surname>
<given-names>Golnaz</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<collab>HPAP consortium</collab>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brissova</surname>
<given-names>Marcela</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Powers</surname>
<given-names>Alvin C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="fn" rid="FN1">10</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232</aff>
<aff id="A2">
<label>2</label>Department of Genetics and Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104</aff>
<aff id="A3">
<label>3</label>Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, 33136</aff>
<aff id="A4">
<label>4</label>Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232</aff>
<aff id="A5">
<label>5</label>Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, 15212</aff>
<aff id="A6">
<label>6</label>Imagine Pharma, Devon, PA, 19333</aff>
<aff id="A7">
<label>7</label>Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, 37232</aff>
<aff id="A8">
<label>8</label>The Human Pancreas Analysis Program (RRID:SCR_016202)</aff>
<aff id="A9">
<label>9</label>VA Tennessee Valley Healthcare System, Nashville, TN, 37212</aff>
<author-notes>
<corresp id="CR1">Correspondence: <email>al.powers@vumc.org</email>; <email>marcela.brissova@vumc.org</email>, Alvin C. Powers or Marcela Brissova, Vanderbilt University Medical Center, 2215 Garland Ave, Nashville, TN 37232-0475</corresp>
<fn id="FN1">
<label>10</label>
<p id="P1">Lead Contact</p>
</fn>
<fn id="FN2">
<label>*</label>
<p id="P2">Co-first authors</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>02</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>31</day>
<month>08</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://europepmc.org/downloads/openaccess">
<license-p>This preprint is made available via the <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/downloads/openaccess">Europe PMC open access subset</ext-link>, for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original preprint source.</license-p>
</license>
</permissions>
<abstract>
<title>Summary/Abstract</title>
<p id="P3">Reports of new-onset diabetes and diabetic ketoacidosis in individuals with COVID-19 have led to the hypothesis that SARS-CoV-2, the virus that causes COVID-19, is directly cytotoxic to pancreatic islet β cells. This would require binding and entry of SARS-CoV-2 into host β cells via cell surface co-expression of ACE2 and TMPRSS2, the putative receptor and effector protease, respectively. To define ACE2 and TMPRSS2 expression in the human pancreas, we examined six transcriptional datasets from primary human islet cells and assessed protein expression by immunofluorescence in pancreata from donors with and without diabetes. <italic>ACE2</italic> and <italic>TMPRSS2</italic> transcripts were low or undetectable in pancreatic islet endocrine cells as determined by bulk or single cell RNA sequencing, and neither protein was detected in α or β cells from these donors. Instead, ACE2 protein was expressed in the islet and exocrine tissue microvasculature and also found in a subset of pancreatic ducts, whereas TMPRSS2 protein was restricted to ductal cells. The absence of significant ACE2 and TMPRSS2 co-expression in islet endocrine cells reduces the likelihood that SARS-CoV-2 directly infects pancreatic islet β cells through these cell entry proteins.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P4">In coronavirus disease of 2019 (COVID-19), elevated plasma glucose levels with or without pre-existing diabetes and BMI have been identified as independent risk factors of morbidity and mortality with severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) infection (<xref ref-type="bibr" rid="R9">Barron et al., 2020</xref>; <xref ref-type="bibr" rid="R19">Cariou et al., 2020</xref>; <xref ref-type="bibr" rid="R34">Holman et al., 2020</xref>; <xref ref-type="bibr" rid="R51">Riddle et al., 2020</xref>; <xref ref-type="bibr" rid="R63">Wang, 2020</xref>; <xref ref-type="bibr" rid="R70">Zhou et al., 2020</xref>). Isolated cases of new-onset diabetes and diabetic emergencies such as ketoacidosis and hyperosmolar hyperglycemia have been reported with COVID-19 (<xref ref-type="bibr" rid="R20">Chee et al., 2020</xref>; <xref ref-type="bibr" rid="R26">Goldman et al., 2020</xref>; <xref ref-type="bibr" rid="R33">Hollstein et al., 2020</xref>; <xref ref-type="bibr" rid="R37">Kim et al., 2020</xref>; <xref ref-type="bibr" rid="R43">Li et al., 2020a</xref>; <xref ref-type="bibr" rid="R50">Rafique and Ahmed, 2020</xref>; <xref ref-type="bibr" rid="R60">Unsworth et al., 2020</xref>), leading to the hypothesis that SARS-CoV-2 has a diabetogenic effect mediated by direct cytotoxicity to pancreatic islet β cells (<xref ref-type="bibr" rid="R39">Koch, 2020</xref>).</p>
<p id="P5">
<italic>In vitro</italic> studies have shown that SARS-CoV-2 entry into human host cells requires binding to the cell surface receptor angiotensin converting enzyme 2 (ACE2) as well as proteolytic cleavage of the viral spike (S) protein by transmembrane serine protease 2 (TMPRSS2) (<xref ref-type="bibr" rid="R32">Hoffmann et al., 2020</xref>; <xref ref-type="bibr" rid="R41">Lan et al., 2020</xref>; <xref ref-type="bibr" rid="R55">Shang et al., 2020</xref>; <xref ref-type="bibr" rid="R65">Wiersinga et al., 2020</xref>). In 2010, Yang and colleagues (<xref ref-type="bibr" rid="R67">Yang et al., 2010</xref>) examined autopsy samples from a single deceased patient infected by SARS-CoV-1, which uses similar machinery for binding and cellular entry, and reported expression of ACE2 in pancreatic islet cells. Though the identity of these islet cells was not assessed, the authors suggested that binding of ACE2 by SARS-CoV-1 damages islets and causes acute diabetes, which could be reversed after viral recovery (<xref ref-type="bibr" rid="R67">Yang et al., 2010</xref>). There have been occasional reports of other viral infections eliciting a diabetogenic effect (reviewed in (<xref ref-type="bibr" rid="R25">Filippi and von Herrath, 2008</xref>)). More recently, Yang and colleagues reported that β-like cells derived from human pluripotent stem cells (hPSCs) as well as β cells of primary human islets express ACE2, raising the possibility of direct infection and cytotoxicity of β cells by SARS-CoV-2 (<xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>). Importantly, neither of these prior studies (<xref ref-type="bibr" rid="R67">Yang et al., 2010</xref>; <xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>) characterized the expression and localization of TMPRSS2, an obligate co-factor for SARS-CoV-2 cellular entry. Thus, a more detailed analysis of both ACE2 and TMPRSS2 expression and localization in human pancreatic tissue from normal donors and those with diabetes is urgently needed. The purpose of this study was to test the hypothesis that native pancreatic islet β cells possess the cellular machinery that could render them direct targets of SARS-CoV-2. Importantly, we found that ACE2 and TMPRSS2 protein are not detectable in human islet endocrine cells from normal donors or those with diabetes, making a direct diabetogenic effect of SARS-CoV-2 via ACE2 and TMPRSS2 unlikely.</p>
</sec>
<sec id="S2" sec-type="results | discussion">
<title>Results and Discussion</title>
<sec id="S3">
<title>
<italic>ACE2</italic> and <italic>TMPRSS2</italic> mRNA expression is minimal in humanα or β cells</title>
<p id="P6">We first evaluated mRNA expression of <italic>ACE2</italic> and <italic>TMPRSS2</italic> from two existing bulk RNA-sequencing (RNA-seq) datasets (<xref ref-type="bibr" rid="R5">Arda et al., 2016</xref>; <xref ref-type="bibr" rid="R10">Blodgett et al., 2015</xref>) where human islet α and β cells were enriched by fluorescence activated cell sorting and compared their expression to that of key islet-enriched genes, some of which are normally expressed at relatively low levels in islet cells (e.g., transcription factors). Median expression level of <italic>ACE2</italic> and <italic>TMPRSS</italic>2 mRNA was much less than transcripts of such key islet-enriched genes in human α and β cells (~84% and 92% lower than α and β cell-enriched transcripts, respectively) (<xref ref-type="fig" rid="F1">Figure 1A</xref>; n=7-8 adult donors per study). In addition, analysis of four single-cell (sc) RNA-seq datasets of human pancreatic cells (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>; <xref ref-type="bibr" rid="R18">Camunas-Soler et al., 2020</xref>; <xref ref-type="bibr" rid="R35">Kaestner et al., 2019</xref>; <xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>) revealed that, in aggregate, less than 1.5% of β cells expressed <italic>ACE2</italic> or <italic>TMPRSS2</italic>, and each transcript was minimally expressed or undetectable in all other endocrine cell subsets (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <xref ref-type="supplementary-material" rid="SD1">S4J</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). We note that this includes analysis of the robust Human Pancreas Analysis Program (HPAP) dataset that includes more than 25,000 cells from 11 normal donors (<xref ref-type="bibr" rid="R35">Kaestner et al., 2019</xref>), findings of which are confirmed in the analyses of three previously reported, but smaller, datasets (<xref ref-type="fig" rid="F1">Figure 1B</xref> and <xref ref-type="supplementary-material" rid="SD1">S4J</xref>). Furthermore, given that <italic>ACE2</italic> and <italic>TMPRSS2</italic> co-expression is required for canonical SARS-CoV-2 host cell entry (<xref ref-type="bibr" rid="R32">Hoffmann et al., 2020</xref>), we also evaluated this occurrence but found that no β cells co-expressed <italic>ACE2</italic> and <italic>TMPRSS2</italic> in any of these four datasets (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>).</p>
<p id="P7">As for non-endocrine cells, the HPAP dataset (<xref ref-type="bibr" rid="R35">Kaestner et al., 2019</xref>) revealed that a small subset (&lt; 5%) of endothelial and stellate cells (which include pericytes) expressed moderate to high levels of <italic>ACE2</italic>, whereas only ~1-3% of either population expressed <italic>ACE2</italic> in the datasets by Baron and colleagues (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>) and Segerstolpe and colleagues (<xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>) (<xref ref-type="fig" rid="F1">Figure 1B</xref>). This difference most likely stems from the number of cells analyzed in that the HPAP dataset contains ~2.5- and 20-fold more cells than that of Baron et al. (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>) or Segerstolpe et al. (<xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>), respectively. In addition, pooled analysis of these datasets (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>; <xref ref-type="bibr" rid="R18">Camunas-Soler et al., 2020</xref>; <xref ref-type="bibr" rid="R35">Kaestner et al., 2019</xref>) showed that less than 1% of acinar or ductal cells expressed <italic>ACE2</italic>, whereas ~35% of both cell types expressed <italic>TMPRSS2</italic>. In the dataset by Segerstolpe and colleagues (<xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>), <italic>ACE2</italic> was expressed in ~20% of acinar and ductal cells, whereas <italic>TMPRSS2</italic> was expressed in greater than 75% of both populations (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Evaluation of <italic>ACE2</italic> and <italic>TMPRSS2</italic> co-expression in non-endocrine cells revealed that on average, less than 1% of acinar, ductal, endothelial and stellate cells co-expressed both transcripts in these datasets (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>; <xref ref-type="bibr" rid="R18">Camunas-Soler et al., 2020</xref>; <xref ref-type="bibr" rid="R35">Kaestner et al., 2019</xref>). In the Segerstolpe et al. dataset (<xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>), ~5% of acinar cells and 15% of ductal cells co-expressed <italic>ACE2</italic> and <italic>TMPRSS2</italic>, but this difference could represent unintended cell selection bias as this study analyzed the fewest number of cells.</p>
<p id="P8">Altogether, these gene expression findings reduce the likelihood that SARS-CoV-2 can bind and enter human β cells via the canonical pathway involving ACE2 and TMPRSS2. However, they do not exclude the possibility of viral entry via non-canonical pathways involving other suggested effector proteases of SARS-CoV-2, such as Cathepsin L (<italic>CTSL</italic>), ADAM metallopeptidase domain 17 (<italic>ADAM17</italic>), <italic>FURIN</italic> and <italic>TMPRSS4</italic> (<xref ref-type="bibr" rid="R13">Breidenbach et al., 2020</xref>; <xref ref-type="bibr" rid="R52">Schreiber et al., 2020</xref>; <xref ref-type="bibr" rid="R54">Seyedpour et al., 2020</xref>; <xref ref-type="bibr" rid="R69">Zang et al., 2020</xref>). We evaluated the expression of these transcripts across all four scRNA-seq datasets and found that with the exception of <italic>TMPRSS4</italic>, each is ubiquitously expressed to varying degrees in all cell types (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). In aggregate, however, less than 1% of β cells co-expressed <italic>ACE2</italic> with <italic>CTSL</italic>, <italic>ADAM17</italic>, <italic>FURIN</italic> or <italic>TMPRSS4</italic> (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). An outstanding question is whether expression of these transcripts in even 1% of β cells is sufficient to confer permissiveness to SARS-CoV-2 infection <italic>in vivo</italic>. Furthermore, heparan sulfate in the extracellular glycocalyx (<xref ref-type="bibr" rid="R22">Clausen et al., 2020</xref>) and motile cilia (present on islet endocrine cells) (<xref ref-type="bibr" rid="R42">Lee et al., 2020</xref>) were mechanisms proposed to assist ACE2-mediated viral entry. Future studies addressing these possibilities in β cells are urgently needed. Notwithstanding, <italic>CTSL</italic>, <italic>ADAM17</italic>, <italic>FURIN</italic> and <italic>TMPRSS4</italic> were more highly expressed in exocrine, endothelial and stellate cells, as was ACE2 (<xref ref-type="fig" rid="F1">Figure 1B</xref>). These gene expression patterns raise the possibility that infection of certain pancreatic cell types by SARS-CoV-2 indirectly impacts β cell function.</p>
<p id="P9">Obesity is a key metabolic risk factor associated with mortality with COVID-19. A recent report noted increased correlation of <italic>TMPRSS2</italic>, but not <italic>ACE2</italic>, expression with BMI (<xref ref-type="bibr" rid="R57">Taneera et al., 2020</xref>). We evaluated the expression of <italic>ACE2</italic>, <italic>TMPRSS2</italic> and <italic>ADAM17</italic> in β cells from 11 donors according to their BMI in our largest sc-RNAseq dataset (<xref ref-type="bibr" rid="R35">Kaestner et al., 2019</xref>). We did not observe changes in the expression of <italic>ACE2</italic> or <italic>TMPRSS2</italic> expression with increasing BMI but observed a trend towards higher <italic>ADAM17</italic> expression (<xref ref-type="supplementary-material" rid="SD1">Figure S1</xref>). However, this dataset included only one patient with an obese BMI. Studies with a larger number of donor islets are needed to address the role of obesity and other pancreas-resident SARS-CoV-2 effector molecules on β cell function in the context of COVID-19.</p>
</sec>
<sec id="S4">
<title>ACE2 and TMPRSS2 protein are not detected in adult or juvenile human isletα or β cells</title>
<p id="P10">Recently, Yang and colleagues (<xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>) reported that ACE2 protein was present in α and β cells from primary human islets and in β-like cells derived from hPSCs. To investigate ACE2 expression, we immunostained cryosections of intact isolated human islets using the same ACE2 antibody as used by Yang and colleagues (<xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>) (antibody validation studies in <xref ref-type="supplementary-material" rid="SD1">Figure S2</xref>). In accordance with the transcriptomic data reported above, ACE2 was not detected in insulin-positive β cells or glucagon-positive α cells in our samples; instead, ACE2 signal was prominent in surrounding cells such as those of the microvasculature (<xref ref-type="fig" rid="F1">Figure 1C</xref>, <bold>top panels</bold>).</p>
<p id="P11">Since hPSC-derived β-like cells differentiated <italic>in vitro</italic> are considered “juvenile-like” and not functionally mature β cells (<xref ref-type="bibr" rid="R46">Nair et al., 2019</xref>), one possibility is that ACE2 is expressed in less differentiated cells, or in the cultured, immortalized β cells (EndoCβH1) studied by Fignani et al. (<xref ref-type="bibr" rid="R48">preprint: Fignani, 2020</xref>). We investigated such a possibility by staining for ACE2 in pancreatic sections from juvenile human donors (age range 5 days to 5 years) using the same ACE2 antibody as used by Yang et al. (<xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>). However, ACE2 was not detected in these juvenile β or α cells (<xref ref-type="fig" rid="F1">Figure 1C</xref>, <bold>bottom panels</bold>), making this explanation less likely.</p>
<p id="P12">To further characterize ACE2 and TMPRSS2 protein expression in the native pancreas, we next analyzed human pancreatic tissue sections from normal donors (ND, n=14; age range 18-59 years) and those with type 2 diabetes (T2D, n=12; age range 42-66 years) or type 1 diabetes (T1D, n=11; age range 13-63 years) for these proteins on the same sections. ACE2 protein did not co-localize with markers of α or β cells but was detected within the distinct islet areas indicative of microvascular structures in all ND individuals (<xref ref-type="fig" rid="F2">Figures 2A-C”, 2D-F”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3A-D</xref>) as well as those with T2D (<xref ref-type="fig" rid="F2">Figures 2G-I”, 2J-L”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3I-L</xref>) or T1D (<xref ref-type="fig" rid="F2">Figures 2M-O”, 2P-R”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3O-R</xref>). We noted similar findings with three additional ACE2-directed antibodies, including the same antibodies and dilutions reported by Yang et al. (<xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>) and by Fignani et al. (<xref ref-type="bibr" rid="R48">preprint: Fignani, 2020</xref>), and one antibody validated by the Human Protein Atlas (HPA) (<xref ref-type="bibr" rid="R31">Hikmet et al., 2020</xref>) (<xref ref-type="supplementary-material" rid="SD1">Figure S2</xref>). Three of these antibodies detect epitopes corresponding to the extracellular domain of ACE2 (AF933; MAB933; HPA000288), while one detects an epitope in the C-terminal domain (ab15348). Staining patterns were similar across all antibodies (<xref ref-type="supplementary-material" rid="SD1">Figure S2</xref>). Furthermore, ACE2 antibody specificity (ab15348) was confirmed via peptide competition with the commercially available immunizing peptide (<xref ref-type="supplementary-material" rid="SD1">Figure S2F-I</xref>).</p>
<p id="P13">TMPRSS2 protein was not detected within islets in ND (<xref ref-type="fig" rid="F2">Figures 2A-C”, 2D-F”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3E-H</xref>), T2D (<xref ref-type="fig" rid="F2">Figures 2G-I”, 2J-L”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3M-N</xref>), or T1D donors (<xref ref-type="fig" rid="F2">Figures 2M-O”, 2P-R”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3S-V</xref>). The TMPRSS2-positive structures in exocrine tissue resembled intercalated and larger ducts as indicated by the typical organization of their nuclei (<xref ref-type="fig" rid="F2">Figures 2C”, 2F”, 2I”, 2L”, 2O”</xref> and <xref ref-type="fig" rid="F2">2R”</xref>). We did not detect differences in the signal intensity or spatial distribution of ACE2 or TMPRSS2 between ND and T2D tissue (<xref ref-type="fig" rid="F2">Figures 2</xref> and <xref ref-type="supplementary-material" rid="SD1">S3</xref>) but labeling for both proteins appeared to be reduced in T1D pancreatic sections (<xref ref-type="fig" rid="F2">Figure 2M-R”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3O-V</xref>). Altogether, these observations indicate that the cell surface proteins required for canonical SARS-CoV-2 host cell entry were not detected on islet endocrine cells from normal or diabetic donors.</p>
<p id="P14">Recent in silico analyses by Vankadari et al. (<xref ref-type="bibr" rid="R62">Vankadari and Wilce, 2020</xref>) and Li et al. (<xref ref-type="bibr" rid="R44">Li et al., 2020b</xref>) suggested that human dipeptidyl peptidase 4 (DPP4) may interact with SARS-CoV-2 and facilitate its entry into host cells. Therefore, we examined the distribution of DPP4 in human pancreas and found that it localized to α cells, but not β cells, of ND, T2D and T1D islets (<xref ref-type="supplementary-material" rid="SD1">Figure S4A-I</xref>). This finding is consistent with our analysis of four scRNA-seq datasets showing <italic>DPP4</italic>-enriched α cells (<xref ref-type="fig" rid="F1">Figures 1B</xref> and <xref ref-type="supplementary-material" rid="SD1">S4J</xref>). Given that we did not detect TMPRSS2 within islets, these data suggest that DPP4 is an unlikely mediator of β cell entry by SARS-CoV-2 (<xref ref-type="bibr" rid="R24">Drucker, 2020</xref>).</p>
<p id="P15">The discrepancy between our findings and those of recent studies identifying ACE2 and TMPRSS2 in human β cells (<xref ref-type="bibr" rid="R67">Yang et al., 2010</xref>) (<xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>) (<xref ref-type="bibr" rid="R48">preprint: Fignani, 2020</xref>) is likely explained by important differences in experimental approaches and contexts. Yang et al. (<xref ref-type="bibr" rid="R67">Yang et al., 2010</xref>) showed ACE2 staining in a single donor islet but did not identify its cellular identity with endocrine markers. Furthermore, the ACE2 antibody used in their study was not reported, which precluded replication of their finding. Fignani et al. (<xref ref-type="bibr" rid="R48">preprint: Fignani, 2020</xref>) identified ACE2 protein in presumed islet endocrine cells from seven non-diabetic donors; however, ACE2 was primarily seen in subcellular compartments rather than the expected cell surface location. Colocalization of ACE2 with insulin granules in this study raises the possibility of a staining artifact. Furthermore, Yang et al. (<xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>) examined ACE2 expression in isolated dispersed human islet cells, whereas our study examined ACE2 in isolated intact islets and in human islets of native pancreata. It is possible that dispersion of pancreatic cells may have altered the expression of ACE2 in this context (<xref ref-type="bibr" rid="R61">van den Brink et al., 2017</xref>). Likewise, sources of variability in immunostaining techniques can stem from differences in tissue fixation procedures, antigen retrieval methods, antibodies used and their dilutions. Notwithstanding, the remarkable concordance of our findings with those from a recent independent effort in native pancreas (Kusmartseva, et al) suggest that differences in experimental conditions may explain the discordance with other studies.</p>
</sec>
<sec id="S5">
<title>ACE2 is localized to islet and exocrine tissue capillaries</title>
<p id="P16">The non-endocrine cell staining pattern of ACE2 in islets prompted us to examine whether ACE2 was expressed in the microvasculature, as described in other organs (<xref ref-type="bibr" rid="R28">Hamming et al., 2004</xref>). Indeed, staining of adult and juvenile human pancreatic tissue sections with CD31, an endothelial cell marker, revealed that ACE2 labeling was localized to the perivascular compartment of islet capillaries (<xref ref-type="fig" rid="F3">Figures 3A-D', I-L'</xref> and <xref ref-type="supplementary-material" rid="SD1">S5A-H'</xref>). In addition, exocrine tissue capillaries, similar to those in islets, showed perivascular ACE2 labeling (<xref ref-type="fig" rid="F3">Figures 3E-H'</xref> and <xref ref-type="supplementary-material" rid="SD1">S5I-P'</xref>). As ACE2-positive cells were scarce in T1D pancreatic tissues (<xref ref-type="fig" rid="F2">Figures 2M, 2O'-O”, 2P, 2R'-R”</xref>, and <xref ref-type="supplementary-material" rid="SD1">S3O-R</xref>), the presence of ACE2 labeling in the perivascular compartment was relatively rare in both islet (<xref ref-type="supplementary-material" rid="SD1">Figure S5E-H'</xref>) and exocrine (<xref ref-type="supplementary-material" rid="SD1">Figure S5M-P'</xref>) T1D tissues. The structure and close relationship between ACE2-positive perivascular cells and CD31-positive endothelial cells in islet and exocrine tissue capillaries raised the possibility that ACE2-positive cells were in fact pericytes enveloping capillary endothelial cells of the vascular tube (<xref ref-type="bibr" rid="R3">Almaca et al., 2018</xref>). In addition, we observed ACE2-positive cytoplasmic processes extending along CD31-positive endothelial cells colocalized with the extracellular matrix marker collagen-IV within the vascular basement membrane (<xref ref-type="fig" rid="F3">Figures 3D', 3H'</xref>, <xref ref-type="supplementary-material" rid="SD1">S5D', S5H', S5L'</xref> and <xref ref-type="supplementary-material" rid="SD1">S5P'</xref>), a pattern that is consistent with pericyte morphology (<xref ref-type="bibr" rid="R3">Almaca et al., 2018</xref>).</p>
<p id="P17">To address this observation more directly, we visualized ACE2 expression in relationship to known pericyte markers and found that ACE2 was enriched in pericyte populations expressing PDGFRβ (<xref ref-type="fig" rid="F4">Figure 4A-D</xref>). Indeed, colocalization analysis revealed that ~60% of ACE2-positive cells were PDGFRβ-positive (<xref ref-type="fig" rid="F4">Figure 4H-I</xref>). Since PDGFRβ labels pericytes and perivascular fibroblasts (<xref ref-type="bibr" rid="R2">Almaca et al., 2020</xref>), we also stained tissues with a more specific pericyte marker, NG2, and found that ~30% of ACE2-positive cells were NG2-positive (<xref ref-type="fig" rid="F4">Figure 4E-G', 4H-I</xref>). These data agree with our scRNA-seq analysis of the HPAP dataset which identified a subset of pericytes, marked by <italic>PDGFRB</italic>, that express moderate levels of <italic>ACE2</italic> (<xref ref-type="fig" rid="F1">Figure 1B</xref>). In addition, our findings support recent reports of pericyte-specific vascular expression of ACE2 in brain and heart tissue (<xref ref-type="bibr" rid="R21">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="R29">He, 2020</xref>). Emerging evidence from both pre-clinical models of SARS-CoV-2 infection (<xref ref-type="bibr" rid="R1">Aid, 2020</xref>) and patients with COVID-19 indicate that cells of the microvasculature (e.g. endothelial cells and pericytes) are requisite contributors to the initiation and propagation of severe disease (<xref ref-type="bibr" rid="R58">Teuwen et al., 2020</xref>). Although we found that <italic>TMPRSS2</italic> expression was negligible in endothelial and stellate cells (which includes pericytes) of human islets, <italic>CTSL</italic>, <italic>ADAM17</italic>, <italic>FURIN</italic> and <italic>ACE2</italic> were moderately to highly expressed in these populations (<xref ref-type="fig" rid="F1">Figure 1B</xref>), raising the intriguing possibility of direct infection of cells in the islet microvasculature by SARS-CoV-2. Such an occurrence could trigger β cell dysfunction and the metabolic sequelae of COVID-19. Future studies addressing this possibility in human islets and pancreatic tissue are urgently needed.</p>
</sec>
<sec id="S6">
<title>Both ACE2 and TMPRSS2 protein are present in pancreatic ducts but rarely are co-expressed</title>
<p id="P18">Our work indicated that TMPRSS2 protein was localized to the apical surface of intercalated and larger ducts in ND (<xref ref-type="fig" rid="F2">Figures 2B, 2C”, 2E, 2F”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3E-H</xref>), T2D (<xref ref-type="fig" rid="F2">Figures 2H, 2I”, 2K, 2L”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3M-N</xref>), and T1D pancreatic tissues (<xref ref-type="fig" rid="F2">Figures 2N, 2O”, 2Q, 2R”</xref> and <xref ref-type="supplementary-material" rid="SD1">S3S-V</xref>). To further define ductal expression of TMPRSS2 and determine whether ACE2 was expressed beyond exocrine tissue capillaries, we visualized expression of these two proteins in relationship to cytokeratin-19 protein (KRT19), a ductal cell marker. TMPRSS2, but not ACE2, was expressed by KRT19-positive cells on the apical surface of intercalated and larger ducts throughout the exocrine compartment (<xref ref-type="fig" rid="F5">Figure 5A-D'</xref>). Rarely, both ACE2 and TMPRSS2 were found on the apical surface of ductal epithelial cells but were spatially distinct (<xref ref-type="fig" rid="F5">Figure 5E-H'</xref>). These findings agree with our scRNA-seq analysis in which <italic>TMPRSS2</italic> was more highly expressed in ductal cells than <italic>ACE2</italic>, but cells positive for both <italic>ACE2</italic> and <italic>TMPRSS2</italic> were rare. In addition, although <italic>TMPRSS2</italic> mRNA was detected in acinar cells by scRNA-seq (<xref ref-type="fig" rid="F1">Figure 1B</xref>), TMPRSS2 protein was undetectable by immunofluorescence analysis (<xref ref-type="fig" rid="F5">Figure 5</xref>), indicating that studies of mRNA and protein may be discordant.</p>
<p id="P19">Because rare cells in the exocrine compartment co-express ACE2 and TMPRSS2, it is possible that SARS-CoV-2 could infect those cells, induce pancreatitis, and consequently impact islet function. While recent case reports of patients with COVID-19 have noted mild elevations of amylase and lipase or frank pancreatitis (<xref ref-type="bibr" rid="R36">Karimzadeh et al., 2020</xref>; <xref ref-type="bibr" rid="R45">Meireles et al., 2020</xref>; <xref ref-type="bibr" rid="R49">Rabice et al., 2020</xref>; <xref ref-type="bibr" rid="R63">Wang et al., 2020</xref>), the vast majority of patients with COVID-19 have neither elevated pancreatic enzymes nor frank pancreatitis (<xref ref-type="bibr" rid="R6">Ashok et al., 2020</xref>; <xref ref-type="bibr" rid="R11">Bonney et al., 2020</xref>; <xref ref-type="bibr" rid="R17">Bruno et al., 2020</xref>). To investigate this possibility, we analyzed the histology of pancreatic tissue obtained at autopsy from seven COVID-19 positive patients, three of whom had diabetes. We did not find signs of pancreatitis, interstitial edema, inflammatory infiltrate, hemorrhage or necrosis (<xref ref-type="fig" rid="F5">Figure 5I</xref>). It is important that exocrine inflammation and ACE2/TMPRSS2 expression be analyzed in a larger number of COVID-19 autopsy samples, particularly in those with new-onset diabetes. Such studies will be challenging since the pancreas rapidly undergoes autolysis upon death.</p>
<p id="P20">In summary, recent reviews, commentaries, and clinical guidelines (<xref ref-type="bibr" rid="R4">Apicella et al., 2020</xref>; <xref ref-type="bibr" rid="R12">Bornstein et al., 2020</xref>; <xref ref-type="bibr" rid="R26">Goldman et al., 2020</xref>; <xref ref-type="bibr" rid="R27">Gupta et al., 2020</xref>; <xref ref-type="bibr" rid="R30">Heaney et al., 2020</xref>) have highlighted an attractive hypothesis of direct cytotoxicity by SARS-CoV-2 to β cells. Here, we addressed the fundamental question of whether canonical SARS CoV-2 cell entry machinery is present in β cells of human pancreatic tissue. By examining pancreatic ACE2 and TMPRSS2 expression in normal donors and in those with diabetes, we found that, <bold>1)</bold> β cells do not coexpress <italic>ACE2</italic> and <italic>TMPRSS2</italic> transcripts by scRNA-seq analysis and neither protein is detectable in α or β cells by immunofluorescence; <bold>2)</bold> ACE2 is primarily expressed in the islet and exocrine tissue capillaries, including pericytes, as well as a subset of ductal cells; <bold>3)</bold> TMPRSS2 is primarily expressed in ductal cells; <bold>4)</bold> ACE2 and TMPRSS2 are infrequently co-expressed in pancreatic ducts; <bold>5)</bold> ACE2 and TMPRSS2 protein expression and distribution appear similar in ND and T2D pancreata but studies on additional pancreata are needed to definitively answer this question; and <bold>6)</bold> Alternative pathways facilitating SARS-CoV-2 viral infection in β cells cannot be excluded. These findings align considerably with independent observations from Kusmartseva and colleagues (Kusmartseva, 2020) and do not support the hypothesis that SARS-CoV-2 binds and infects islet β cells via a canonical pathway mediated by ACE2 and TMPRSS2, eliciting a diabetogenic effect. As outlined below in the “Limitations of the Study” section, additional studies are needed to investigate whether direct SARS-CoV-2 infection of β cells occurs or is detrimental to β cell health or function by other mechanisms. However, based on current data, it appears that the interaction of diabetes and SARS-CoV-2 is mediated by systemic inflammation and/or metabolic changes in other organs such as liver, muscle or adipose tissue.</p>
</sec>
<sec id="S7">
<title>Limitations of the Study</title>
<p id="P21">We did not directly measure SARS-CoV-2 binding or entry into human β cells but instead assessed expression of canonical co-receptors, ACE2 and TMPRSS2, in the human pancreas. While studies culturing SARS-CoV-2 and human islets <italic>in vitro</italic> will be of considerable interest, such experiments may be challenging to interpret as the islet isolation process itself may impact ACE2 or TMPRSS2 expression or susceptibility to viral infection. In addition, infection of islet cells within an intact, isolated islet with a variety of viruses has proven difficult as is selection of an appropriate ratio of viral particles and islet cells reflective of the <italic>in vivo</italic> environment. Furthermore, it is not clear if infection of an isolated islet accurately models the physiology of a vascularized, innervated islet within the context of the pancreas.</p>
<p id="P22">While the preponderance of research suggests that ACE2 and TMPRSS2 are the primary means for SARS-CoV-2 entry into host cells, knowledge about additional pathways and/or mechanisms of SARS-CoV-2 cell entry and infection is rapidly evolving. We sought, but did not find evidence, suggesting that other proposed pathways (namely <italic>DPP4</italic>, <italic>CTSL</italic>, <italic>ADAM17</italic>, <italic>FURIN</italic> or <italic>TMPRSS4</italic>) are involved in β cell entry.</p>
<p id="P23">We did not assess the presence of SARS-CoV-2, its proteins, or RNA in the pancreas from COVID-19-infected individuals. It is possible that SARS-CoV-2 could infect pancreatic exocrine cells, ductal cells, endothelial cells, or microvasculature, leading to pancreatic inflammation that negatively impacts β cell health or function. We did not find evidence of inflammation in the pancreas of seven COVID-19-infected patients (three of whom had diabetes). Future efforts are needed to collect a large number of pancreata from COVID-19-infected individuals with and without diabetes (long-standing and recent-onset) to search for presence of SARS-CoV-2 or inflammation (islet or exocrine). Since the pancreas undergoes rapid autolysis after death, care must be taken to collect the pancreas very soon after death for this analysis.</p>
</sec>
</sec>
<sec sec-type="methods" id="S8" specific-use="web-only">
<title>Star Methods</title>
<sec id="S9">
<title>Resource Availability</title>
<sec id="S10">
<title>Lead contact</title>
<p id="P24">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Alvin C. Powers (<email>al.powers@vumc.org</email>).</p>
</sec>
<sec id="S11" sec-type="materials">
<title>Materials Availability</title>
<p id="P25">This study did not generate new unique reagents.</p>
</sec>
<sec id="S12">
<title>Data and Code Availability</title>
<p id="P26">All data generated or analyzed during this study are included in this published article or in the data repositories listed in the Key Resources Table. Original/source data for <xref ref-type="fig" rid="F1">Figure 1A</xref> (bulk RNA-seq of FACS sorted human islet α and β cells) is available under NCBI GEO accession numbers GSE67543 (<xref ref-type="bibr" rid="R10">Blodgett et al., 2015</xref>) and GSE57973 (<xref ref-type="bibr" rid="R5">Arda et al., 2016</xref>). Original/source data for <xref ref-type="fig" rid="F1">Figure 1B</xref> and <xref ref-type="supplementary-material" rid="SD1">Figure S4J</xref> (single cell RNA-seq of human islets) is available under NCBI GEO accession number GSE84133 (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>), GSE124742 (<xref ref-type="bibr" rid="R18">Camunas-Soler et al., 2020</xref>), and ArrayExpress (EBI) accession number E-MTAB-5061 (<xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>). This manuscript used data acquired from the Human Pancreas Analysis Program (HPAP) Database (<ext-link ext-link-type="uri" xlink:href="https://hpap.pmacs.upenn.edu">https://hpap.pmacs.upenn.edu</ext-link>), a Human Islet Research Network consortium.</p>
</sec>
</sec>
<sec id="S13">
<title>Experimental Model and Subject Details</title>
<sec id="S14">
<title>Human Subjects</title>
<p id="P27">Pancreata and islets from juvenile, adult, T1D and T2D human donors were obtained through partnerships with the International Institute for Advancement of Medicine (IIAM), National Disease Research Interchange (NDRI), Integrated Islet Distribution Program (IIDP), and local organ procurement organizations. Pancreata from normal donors were processed either for islet isolation (<xref ref-type="bibr" rid="R7">Balamurugan et al., 2003</xref>) and/or histological analysis as described previously (described below and in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>) (<xref ref-type="bibr" rid="R16">Brissova et al., 2018</xref>; <xref ref-type="bibr" rid="R23">Dai et al., 2017</xref>). Pancreata from COVID-19 decedents after autopsy were obtained from the Translational Pathology Shared Resource (TPSR) at Vanderbilt University Medical Center (Nashville, TN) and and processed for histological analysis as according to standard procedures for clinical diagnostics (VUMC Histology Peloris Processing Protocol). Samples from donors of both sexes were used in our analyses. Donor demographic information is summarized in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>. The Vanderbilt University Institutional Review Board does not consider de-identified human pancreatic specimens to be human subjects research.</p>
</sec>
</sec>
</sec>
<sec id="S15" sec-type="methods">
<title>Method Details</title>
<sec id="S16">
<title>Human Pancreas Procurement and Preparation of Tissue for Histological Analysis</title>
<p id="P28">Pancreata from juvenile, adult, T1D and T2D donors were obtained within 18 hours from cross-clamp and maintained in cold preservation solution on ice until processing, as described previously (<xref ref-type="bibr" rid="R7">Balamurugan et al., 2003</xref>; <xref ref-type="bibr" rid="R16">Brissova et al., 2018</xref>). Pancreata recovered from seven COVID-19 decedants were obtained from Vanderbilt University Medical Center (Nashville, TN) within 8-27 hours of death. Donor demographic information is summarized in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>. Human kidney samples were provided by Dr. Agnes Fogo, Vanderbilt University. The Vanderbilt University Institutional Review Board has declared that studies on de-identified human pancreatic specimens do not quality as human subjects research.</p>
</sec>
<sec id="S17">
<title>Mouse Tissue Preparation for Histological Analysis</title>
<p id="P29">Mice were maintained on standard rodent chow under a 12-hour light/dark cycle. Kidney from adult NOD.<italic>Cg-Prkdc<sup>scid</sup>Il2rg<sup>tm1Wjl</sup>
</italic>/ Sz (NSG) mice ages 12 to 18 weeks (Jackson Laboratory) were isolated. Tissue specimens were processed for cryosections as described previously (<xref ref-type="bibr" rid="R16">Brissova et al., 2018</xref>).</p>
</sec>
<sec id="S18">
<title>Immunohistochemical Analysis</title>
<p id="P30">Immunohistochemical analysis was performed on 5-μm cryosections (<xref ref-type="fig" rid="F1">Figure 1C</xref>; <xref ref-type="fig" rid="F3">Figure 3</xref> and <xref ref-type="fig" rid="F4">4</xref>; <xref ref-type="supplementary-material" rid="SD1">Figure S2:A-I; S3A-D, I-L and O-R; S4 and S5</xref>) or formalin-fixed paraffin embedded (FFPE) pancreatic sections (<xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="fig" rid="F5">5</xref>; <xref ref-type="supplementary-material" rid="SD1">Figure S2:J-W; S3E-H, M-N and S-V</xref>) as indicated and described previously (<xref ref-type="bibr" rid="R14">Brissova et al., 2014</xref>; <xref ref-type="bibr" rid="R16">Brissova et al., 2018</xref>; <xref ref-type="bibr" rid="R66">Wright et al., 2020</xref>). FFPE sections were first deparaffinized in xylene and ethanol followed by heat-induced epitope retrieval in a citrate-based antigen unmasking solution, pH 6.0 (see <xref ref-type="table" rid="T1">Key Resource Table</xref>). Immunofluorescence analysis of isolated islets was performed on 8-μm cryosections of islets embedded in collagen gels as described previously (<xref ref-type="bibr" rid="R15">Brissova et al., 2005</xref>; <xref ref-type="bibr" rid="R16">Brissova et al., 2018</xref>). Primary antibodies to all antigens and their working dilutions are listed in the <xref ref-type="table" rid="T1">Key Resource Table</xref>. The antigens were visualized using appropriate secondary antibodies listed in the <xref ref-type="table" rid="T1">Key Resource Table</xref>. Digital images were acquired with an Olympus FLUOVIEW FV3000 laser scanning confocal microscope (Olympus Corporation).</p>
</sec>
<sec id="S19">
<title>Peptide Competition</title>
<p id="P31">We combined 1μg of anti-ACE2 antibody (ab15348) with or without 10μg of the immunizing human ACE2 peptide (ab15352) in antibody buffer solution (0.1% Triton X-100/1% BSA/1X PBS) and incubated overnight at 4°C with gentle agitation.</p>
<p id="P32">Immunofluorescence staining of 5-μm serial cryosections from the same donor was performed as described above. One section was incubated with the neutralized antibody buffer while the other section was incubated with the non-neutralized antibody buffer. ACE2 staining patterns were visualized via confocal microscopy as described above.</p>
</sec>
<sec id="S20">
<title>H&amp;E Staining</title>
<p id="P33">FFPE pancreas tissue sections (5-μm sections, n=7 donors) were processed according to standard procedures for clinical diagnostics (Vanderbilt University Medical Center Histology Peloris Processing Protocols). Slides were stained with hematoxylin &amp; eosin and reviewed by a clinical pathologist (M.E.K.) at Vanderbilt University Medical Center.</p>
</sec>
<sec id="S21">
<title>Bulk RNA-seq Data Acquisition</title>
<p id="P34">Transcripts Per Million (TPM) and Reads Per Kilobase Per Million (RPKM) normalized counts were extracted from publicly available RNA-seq datasets (<xref ref-type="bibr" rid="R5">Arda et al., 2016</xref>; <xref ref-type="bibr" rid="R10">Blodgett et al., 2015</xref>). The sources of the datasets are summarized in the Key Resources Table. GraphPad Prism v8 was used to generate plots in <xref ref-type="fig" rid="F1">Figure 1A</xref>.</p>
</sec>
<sec id="S22">
<title>Single Cell RNA-seq Data Acquisition</title>
<p id="P35">Raw gene count matrices were extracted from existing single cell RNA-seq datasets (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>; <xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>; <xref ref-type="bibr" rid="R68">Yang et al., 2020</xref>) and from the Human Pancreas Analysis Program (HPAP) Database (<ext-link ext-link-type="uri" xlink:href="https://hpap.pmacs.upenn.edu">https://hpap.pmacs.upenn.edu</ext-link>), a Human Islet Research Network consortium. The sources of the datasets are summarized in the Key Resources Table. Gene count matrices were further analyzed using the R package Seurat version 3.1 (<xref ref-type="bibr" rid="R56">Stuart et al., 2019</xref>). Gene count measurements were normalized for each cell by library size and log-transformed using a size factor of 10,000 molecules per cell. The data was further scaled to unit variance and zero mean implemented in the “ScaleData” function. Cell types already annotated by the authors in the original study were used and thus, no clustering was performed. Seurat's “DotPlot” function was used to generate plots shown in <xref ref-type="fig" rid="F1">Figures 1B</xref> and <xref ref-type="supplementary-material" rid="SD1">S4J</xref> to visualize <italic>ACE2</italic> and <italic>TMPRSS</italic>2 scaled expression.</p>
</sec>
</sec>
<sec id="S23">
<title>Quantification and Statistical Analysis</title>
<sec id="S24">
<title>Statistical analysis</title>
<p id="P36">Bulk RNA-seq data are expressed as mean ± standard error of mean (<xref ref-type="fig" rid="F1">Figures 1A</xref>). Sample size (n) is provided as the number of independent donor samples. A p-value less than 0.05 was considered significant. Statistical analysis (unpaired t-test) was performed using GraphPad Prism software. Mander's coefficients were determined to quantify colocalization between pericyte markers (NG2 and PDGFRβ) and ACE2 in confocal images of islets using the ImageJ plugin “Just Another Co-localization Plugin”: (<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/plugins/track/jacop2.html">https://imagej.nih.gov/ij/plugins/track/jacop2.html</ext-link>).</p>
</sec>
</sec>
<sec id="S25">
<title>Additional Resources</title>
<p id="P37">None.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary tables and figures</label>
<media xlink:href="EMS94425-supplement-Supplementary_tables_and_figures.pdf" mimetype="application" mime-subtype="pdf" id="N67411" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S26">
<title>Acknowledgements</title>
<p>We are especially thankful to organ donors and their families. This research was supported by funding provided by the National Institute of Diabetes and Digestive and Kidney Diseases, the Human Islet Research Network (HIRN; RRID:SCR_014393; <ext-link ext-link-type="uri" xlink:href="https://hirnetwork.org">https://hirnetwork.org</ext-link>; DK112232, DK123716, U01DK123594, DK104211, DK108120), and by DK106755, DK117147, DK117147-01A1S1, DK111757, DK112217, DK20593, and the Functional Genomics Core of DK19525. This manuscript used data acquired from and available at the Human Pancreas Analysis Program (HPAP-RRID:SCR_016202) Database (<ext-link ext-link-type="uri" xlink:href="https://hpap.pmacs.upenn.edu">https://hpap.pmacs.upenn.edu</ext-link>), a HIRN consortium. This work was also supported by grants from the Doris Duke Charitable Foundation (DDCF 4043516256), Human Islet Research Network New Investigator Pilot Award (UC4 DK104162), JDRF, The Leona M. and Harry B. Helmsley Charitable Trust, and the Department of Veterans Affairs (BX000666). Human pancreatic islets were provided by the NIDDK-funded Integrated Islet Distribution Program at the City of Hope (NIH Grant # 2UC4 DK098085 RRID: SCR_014387; <ext-link ext-link-type="uri" xlink:href="http://iidp.coh.org">http://iidp.coh.org</ext-link>). Human kidney sections were provided by Dr. Agnes B. Fogo at Vanderbilt University Medical Center. We thank Amber M. Bradley for technical assistance.</p>
</ack>
<fn-group>
<fn id="FN3" fn-type="con">
<p id="P38">
<bold>Author Contributions:</bold> K.C. J.C., M.B., and A.C.P. designed the experiments. K.C., J.C., M.B., and A.C.P. wrote the manuscript. K.C., J.C., S.S., W.W., L.G. J.A., M.E.K., M.F., A.M., C.D., D.S., R.B., R.J., R.W.S., K.L.H., G.V., M.B., and A.C.P. performed experiments or analyzed the data. All authors reviewed and edited the final manuscript. As the lead contact, A.C.P. is responsible for: 1) communication with the journal and co-authors; 2) addressing requests for reagents and resources; and 3) overseeing decisions and disputes related to the manuscript.</p>
</fn>
<fn id="FN4" fn-type="conflict">
<p id="P39">
<bold>Declaration of Interests:</bold> The authors declare no conflicts of interests.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Busman-Sahay</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maliga</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bondoc</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Starke</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Terry</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wrijil</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ducat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brook</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>
<article-title>Vascular disease and thrombosis in SARS-CoV-2 infected Rhesus macaques</article-title>
<source>Cell</source>
<year>2020</year>
<comment>In Press</comment>
</element-citation>
</ref>
<ref id="R2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almaca</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Caicedo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Landsman</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Beta cell dysfunction in diabetes: the islet microenvironment as an unusual suspect</article-title>
<source>Diabetologia</source>
<year>2020</year>
<volume>63</volume>
<fpage>2076</fpage>
<lpage>2085</lpage>
</element-citation>
</ref>
<ref id="R3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almaca</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weitz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rodriguez-Diaz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Caicedo</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The pericyte of the pancreatic islet regulates capillary diameter and local blood flow</article-title>
<source>Cell Metab</source>
<year>2018</year>
<volume>27</volume>
<fpage>630</fpage>
<lpage>644</lpage>
<comment>e634</comment>
</element-citation>
</ref>
<ref id="R4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Apicella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Campopiano</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Mantuano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mazoni</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Coppelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Del Prato</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>COVID-19 in people with diabetes: understanding the reasons for worse outcomes</article-title>
<source>Lancet Diabetes Endocrinol</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arda</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Rosli</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Peiris</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Spitale</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Age-dependent pancreatic gene regulation reveals mechanisms governing human beta cell function</article-title>
<source>Cell Metab</source>
<year>2016</year>
<volume>23</volume>
<fpage>909</fpage>
<lpage>920</lpage>
</element-citation>
</ref>
<ref id="R6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashok</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Faghih</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>VK</given-names>
</name>
</person-group>
<article-title>Mild pancreatic enzyme elevations in COVID-19 pneumonia: synonymous with injury or noise</article-title>
<source>Gastroenterology</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balamurugan</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Isolation, culture, and functional characteristics of diabetic islets [corrected]</article-title>
<source>Pancreas</source>
<year>2003</year>
<volume>26</volume>
<fpage>102</fpage>
<lpage>103</lpage>
</element-citation>
</ref>
<ref id="R8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Veres</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wolock</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Faust</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Gaujoux</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vetere</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Shen-Orr</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>AM</given-names>
</name>
<etal/>
</person-group>
<article-title>A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure</article-title>
<source>Cell Syst</source>
<year>2016</year>
<volume>3</volume>
<fpage>346</fpage>
<lpage>360</lpage>
<comment>e344</comment>
</element-citation>
</ref>
<ref id="R9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barron</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bakhai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Knighton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Holman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Khunti</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sattar</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study</article-title>
<source>Lancet Diabetes Endocrinol</source>
<year>2020</year>
<volume>8</volume>
<fpage>813</fpage>
<lpage>822</lpage>
</element-citation>
</ref>
<ref id="R10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blodgett</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Nowosielska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Afik</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pechhold</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cura</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kucukural</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>SC</given-names>
</name>
<etal/>
</person-group>
<article-title>Novel observations from next-generation RNA sequencing of highly purified human adult and fetal islet cell subsets</article-title>
<source>Diabetes</source>
<year>2015</year>
<volume>64</volume>
<fpage>3172</fpage>
<lpage>3181</lpage>
</element-citation>
</ref>
<ref id="R11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonney</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Windsor</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>SARS-COV-2 associated acute pancreatitis: Cause, consequence or epiphenomenon</article-title>
<source>Pancreatology</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bornstein</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Rubino</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Khunti</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mingrone</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hopkins</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Birkenfeld</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Boehm</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Amiel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Skyler</surname>
<given-names>JS</given-names>
</name>
<etal/>
</person-group>
<article-title>Practical recommendations for the management of diabetes in patients with COVID-19</article-title>
<source>Lancet Diabetes Endocrinol</source>
<year>2020</year>
<volume>8</volume>
<fpage>546</fpage>
<lpage>550</lpage>
</element-citation>
</ref>
<ref id="R13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breidenbach</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Dube</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abdullah</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Modyanov</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dworkin</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Impact of Comorbidities on SARS-CoV-2 Viral Entry-Related Genes</article-title>
<source>J Pers Med</source>
<year>2020</year>
<volume>10</volume>
</element-citation>
</ref>
<ref id="R14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brissova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aamodt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Brahmachary</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mellati</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shostak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Poffenberger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Aramandla</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes beta cell regeneration</article-title>
<source>Cell Metab</source>
<year>2014</year>
<volume>19</volume>
<fpage>498</fpage>
<lpage>511</lpage>
</element-citation>
</ref>
<ref id="R15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brissova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hirshberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Harlan</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy</article-title>
<source>J Histochem Cytochem</source>
<year>2005</year>
<volume>53</volume>
<fpage>1087</fpage>
<lpage>1097</lpage>
</element-citation>
</ref>
<ref id="R16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brissova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haliyur</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shrestha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Blodgett</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Bottino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Campbell-Thompson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aramandla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Poffenberger</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>alpha Cell Function and Gene Expression Are Compromised in Type 1 Diabetes</article-title>
<source>Cell Rep</source>
<year>2018</year>
<volume>22</volume>
<fpage>2667</fpage>
<lpage>2676</lpage>
</element-citation>
</ref>
<ref id="R17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruno</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fabrizio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Santoro</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Buccoliero</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Pancreatic injury in the course of coronavirus disease 2019: A not-so-rare occurrence</article-title>
<source>J Med Virol</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camunas-Soler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Hang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bautista</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Quake</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>PE</given-names>
</name>
</person-group>
<article-title>Patch-seq links single-cell transcriptomes to human islet dysfunction in diabetes</article-title>
<source>Cell Metab</source>
<year>2020</year>
<volume>31</volume>
<fpage>1017</fpage>
<lpage>1031</lpage>
<comment>e1014</comment>
</element-citation>
</ref>
<ref id="R19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cariou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hadjadj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wargny</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pichelin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Al-Salameh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Allix</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Amadou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Arnault</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Baudoux</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bauduceau</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study</article-title>
<source>Diabetologia</source>
<year>2020</year>
<volume>63</volume>
<fpage>1500</fpage>
<lpage>1515</lpage>
</element-citation>
</ref>
<ref id="R20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chee</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>SJH</given-names>
</name>
<name>
<surname>Yeoh</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus</article-title>
<source>Diabetes Res Clin Pract</source>
<year>2020</year>
<volume>164</volume>
<comment>108166</comment>
</element-citation>
</ref>
<ref id="R21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2</article-title>
<source>Cardiovasc Res</source>
<year>2020</year>
<volume>116</volume>
<fpage>1097</fpage>
<lpage>1100</lpage>
</element-citation>
</ref>
<ref id="R22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clausen</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Sandoval</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Spliid</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Pihl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Perrett</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Painter</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Narayanan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Majowicz</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>McVicar</surname>
<given-names>RN</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2</article-title>
<source>Cell</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shostak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Poffenberger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Greiner</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Shultz</surname>
<given-names>LD</given-names>
</name>
<etal/>
</person-group>
<article-title>Age-dependent human beta cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling</article-title>
<source>J Clin Invest</source>
<year>2017</year>
<volume>127</volume>
<fpage>3835</fpage>
<lpage>3844</lpage>
</element-citation>
</ref>
<ref id="R24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drucker</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications</article-title>
<source>Endocr Rev</source>
<year>2020</year>
<volume>41</volume>
</element-citation>
</ref>
<ref id="R25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filippi</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>von Herrath</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Viral trigger for type 1 diabetes: pros and cons</article-title>
<source>Diabetes</source>
<year>2008</year>
<volume>57</volume>
<fpage>2863</fpage>
<lpage>2871</lpage>
</element-citation>
</ref>
<ref id="R26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YN</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care</article-title>
<source>Diabetes Res Clin Pract</source>
<year>2020</year>
<volume>166</volume>
<comment>108291</comment>
</element-citation>
</ref>
<ref id="R27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Madhavan</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Sehgal</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sehrawat</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Bikdeli</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ahluwalia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ausiello</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>EY</given-names>
</name>
<etal/>
</person-group>
<article-title>Extrapulmonary manifestations of COVID-19</article-title>
<source>Nat Med</source>
<year>2020</year>
<volume>26</volume>
<fpage>1017</fpage>
<lpage>1032</lpage>
</element-citation>
</ref>
<ref id="R28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamming</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Timens</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bulthuis</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Lely</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Navis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van Goor</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis</article-title>
<source>J Pathol</source>
<year>2004</year>
<volume>203</volume>
<fpage>631</fpage>
<lpage>637</lpage>
</element-citation>
</ref>
<ref id="R29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mae</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Muhl</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nahar</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2 – implications for microvascular inflammation and hypercoagulopathy in COVID-19 patients</article-title>
<source>Biorxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heaney</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection</article-title>
<source>Am J Emerg Med</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hikmet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mear</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Edvinsson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Micke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Uhlen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lindskog</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The protein expression profile of ACE2 in human tissues</article-title>
<source>Mol Syst Biol</source>
<year>2020</year>
<volume>16</volume>
<fpage>e9610</fpage>
</element-citation>
</ref>
<ref id="R32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kleine-Weber</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kruger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Herrler</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Erichsen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schiergens</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Herrler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Nitsche</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<fpage>271</fpage>
<lpage>280</lpage>
<comment>e278</comment>
</element-citation>
</ref>
<ref id="R33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollstein</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gluck</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Bonifacio</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wendorff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schreiber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bornstein</surname>
<given-names>SR</given-names>
</name>
<etal/>
</person-group>
<article-title>Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report</article-title>
<source>Nat Metab</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Knighton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>O'Keefe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Curley</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barron</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bakhai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Khunti</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wareham</surname>
<given-names>NJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study</article-title>
<source>Lancet Diabetes Endocrinol</source>
<year>2020</year>
<volume>8</volume>
<fpage>823</fpage>
<lpage>833</lpage>
</element-citation>
</ref>
<ref id="R35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaestner</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Naji</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Consortium</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP)</article-title>
<source>Diabetes</source>
<year>2019</year>
<volume>68</volume>
<fpage>1394</fpage>
<lpage>1402</lpage>
</element-citation>
</ref>
<ref id="R36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karimzadeh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Manzuri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ebrahimi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huy</surname>
<given-names>NT</given-names>
</name>
</person-group>
<article-title>COVID-19 presenting as acute pancreatitis: Lessons from a patient in Iran</article-title>
<source>Pancreatology</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>NY</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>EY</given-names>
</name>
</person-group>
<article-title>Acute hyperglycemic crises with coronavirus disease-19: case reports</article-title>
<source>Diabetes Metab J</source>
<year>2020</year>
<volume>44</volume>
<fpage>349</fpage>
<lpage>353</lpage>
</element-citation>
</ref>
<ref id="R38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Mazutis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Akartuna</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tallapragada</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Veres</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Peshkin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Weitz</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Kirschner</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells</article-title>
<source>Cell</source>
<year>2015</year>
<volume>161</volume>
<fpage>1187</fpage>
<lpage>1201</lpage>
</element-citation>
</ref>
<ref id="R39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bennet</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>COVID-19 and diabetes: a co-conspiracy</article-title>
<source>Lancet Diabetes Endocrinol</source>
<year>2020</year>
<volume>8</volume>
<fpage>801</fpage>
</element-citation>
</ref>
<ref id="R40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kusmartseva</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Syed</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Van Der Heide</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Jorgensen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Candelario-Jalil</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nick</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Harbert</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>ACE2 and SARS-CoV-2 Expression in the Normal and COVID-19 Pancreas</article-title>
<source>Biorxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</article-title>
<source>Nature</source>
<year>2020</year>
<volume>581</volume>
<fpage>215</fpage>
<lpage>220</lpage>
</element-citation>
</ref>
<ref id="R42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>IT</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Goltsev</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gall</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Schurch</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>McIlwain</surname>
<given-names>DR</given-names>
</name>
<etal/>
</person-group>
<article-title>Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers</article-title>
<source>medRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>COVID-19 infection may cause ketosis and ketoacidosis</article-title>
<source>Diabetes Obes Metab</source>
<year>2020a</year>
</element-citation>
</ref>
<ref id="R44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike</article-title>
<source>iScience</source>
<year>2020b</year>
<volume>23</volume>
<comment>101160</comment>
</element-citation>
</ref>
<ref id="R45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meireles</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Bessa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gaspar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Parreira</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Mota</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Alvoeiro</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Acalculous acute pancreatitis in a COVID-19 patient</article-title>
<source>Eur J Case Rep Intern Med</source>
<year>2020</year>
<volume>7</volume>
<comment>001710</comment>
</element-citation>
</ref>
<ref id="R46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nair</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Russ</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saxton</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Juang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>VQ</given-names>
</name>
<name>
<surname>Giacometti</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived beta cells</article-title>
<source>Nat Cell Biol</source>
<year>2019</year>
<volume>21</volume>
<fpage>263</fpage>
<lpage>274</lpage>
</element-citation>
</ref>
<ref id="R47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Picelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Faridani</surname>
<given-names>OR</given-names>
</name>
<name>
<surname>Bjorklund</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Winberg</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sagasser</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sandberg</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Full-length RNA-seq from single cells using Smart-seq2</article-title>
<source>Nat Protoc</source>
<year>2014</year>
<volume>9</volume>
<fpage>171</fpage>
<lpage>181</lpage>
</element-citation>
</ref>
<ref id="R48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fignani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Licata</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Brusco</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nigi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grieco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Marselli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Overbergh</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gysemans</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Colli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marchetti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mathieu</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 is expressed in human pancreatic islet β-cells and is upregulated by inflammatory stress</article-title>
<source>BioRxiv</source>
<year>2020</year>
<comment>preprint</comment>
</element-citation>
</ref>
<ref id="R49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabice</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Altshuler</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Bovet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gagnon</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>COVID-19 infection presenting as pancreatitis in a pregnant woman: A case report</article-title>
<source>Case Rep Womens Health</source>
<year>2020</year>
<volume>27</volume>
<fpage>e00228</fpage>
</element-citation>
</ref>
<ref id="R50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rafique</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>FW</given-names>
</name>
</person-group>
<article-title>A Case of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in a Patient With COVID-19</article-title>
<source>Cureus</source>
<year>2020</year>
<volume>12</volume>
<fpage>e8965</fpage>
</element-citation>
</ref>
<ref id="R51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riddle</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Buse</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Franks</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Knowler</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Ratner</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Selvin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wexler</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>COVID-19 in people with diabetes: urgently needed lessons from early reports</article-title>
<source>Diabetes Care</source>
<year>2020</year>
<volume>43</volume>
<fpage>1378</fpage>
<lpage>1381</lpage>
</element-citation>
</ref>
<ref id="R52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreiber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Shedding Light on COVID-19: ADAM17 the Missing Link</article-title>
<source>Am J Ther</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Segerstolpe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Palasantza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eliasson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Andreasson</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Picelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sabirsh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Clausen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bjursell</surname>
<given-names>MK</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes</article-title>
<source>Cell Metab</source>
<year>2016</year>
<volume>24</volume>
<fpage>593</fpage>
<lpage>607</lpage>
</element-citation>
</ref>
<ref id="R54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seyedpour</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khodaei</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Loghman</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Seyedpour</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kisomi</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Balibegloo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nezamabadi</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Gholami</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Saghazadeh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rezaei</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies</article-title>
<source>J Cell Physiol</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Auerbach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Cell entry mechanisms of SARS-CoV-2</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2020</year>
<volume>117</volume>
<fpage>11727</fpage>
<lpage>11734</lpage>
</element-citation>
</ref>
<ref id="R56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stuart</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hafemeister</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Papalexi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mauck</surname>
<given-names>WM</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Hao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Stoeckius</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smibert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Satija</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Comprehensive Integration of Single-Cell Data</article-title>
<source>Cell</source>
<year>2019</year>
<volume>177</volume>
<fpage>1888</fpage>
<lpage>1902</lpage>
<comment>e1821</comment>
</element-citation>
</ref>
<ref id="R57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taneera</surname>
<given-names>J</given-names>
</name>
<name>
<surname>El-Huneidi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hamad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mohammed</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Elaraby</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hachim</surname>
<given-names>MY</given-names>
</name>
</person-group>
<article-title>Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors</article-title>
<source>Biology (Basel)</source>
<year>2020</year>
<volume>9</volume>
</element-citation>
</ref>
<ref id="R58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teuwen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Geldhof</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pasut</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carmeliet</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>COVID-19: the vasculature unleashed</article-title>
<source>Nat Rev Immunol</source>
<year>2020</year>
<volume>20</volume>
<fpage>389</fpage>
<lpage>391</lpage>
</element-citation>
</ref>
<ref id="R59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uhlen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hallstrom</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Lindskog</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Oksvold</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mardinoglu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sivertsson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kampf</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sjostedt</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Asplund</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Proteomics. Tissue-based map of the human proteome</article-title>
<source>Science</source>
<year>2015</year>
<volume>347</volume>
<comment>1260419</comment>
</element-citation>
</ref>
<ref id="R60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unsworth</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kshirsagar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Naidu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>RMW</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Logan</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K</article-title>
<source>Diabetes Care</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Brink</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Sage</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Vertesy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Spanjaard</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Peterson-Maduro</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>van Oudenaarden</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations</article-title>
<source>Nat Methods</source>
<year>2017</year>
<volume>14</volume>
<fpage>935</fpage>
<lpage>936</lpage>
</element-citation>
</ref>
<ref id="R62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vankadari</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wilce</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</article-title>
<source>Emerg Microbes Infect</source>
<year>2020</year>
<volume>9</volume>
<fpage>601</fpage>
<lpage>604</lpage>
</element-citation>
</ref>
<ref id="R63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia</article-title>
<source>Gastroenterology</source>
<year>2020</year>
<volume>159</volume>
<fpage>367</fpage>
<lpage>370</lpage>
</element-citation>
</ref>
<ref id="R64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study</article-title>
<source>Diabetologia</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiersinga</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Rhodes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Peacock</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Prescott</surname>
<given-names>HC</given-names>
</name>
</person-group>
<article-title>Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review</article-title>
<source>JAMA</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Poffenberger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Serreze</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Harlan</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Bottino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brissova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Decreased pancreatic acinar cell number in type 1 diabetes</article-title>
<source>Diabetologia</source>
<year>2020</year>
<volume>63</volume>
<fpage>1418</fpage>
<lpage>1423</lpage>
</element-citation>
</ref>
<ref id="R67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>LM</given-names>
</name>
</person-group>
<article-title>Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes</article-title>
<source>Acta Diabetol</source>
<year>2010</year>
<volume>47</volume>
<fpage>193</fpage>
<lpage>199</lpage>
</element-citation>
</ref>
<ref id="R68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nilsson-Payant</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jaffre</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids</article-title>
<source>Cell Stem Cell</source>
<year>2020</year>
<volume>27</volume>
<fpage>125</fpage>
<lpage>136</lpage>
<comment>e127</comment>
</element-citation>
</ref>
<ref id="R69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gomez Castro</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>McCune</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Rothlauf</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Sonnek</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Brulois</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>HB</given-names>
</name>
<etal/>
</person-group>
<article-title>TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes</article-title>
<source>Sci Immunol</source>
<year>2020</year>
<volume>5</volume>
</element-citation>
</ref>
<ref id="R70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>
<article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>395</volume>
<fpage>1054</fpage>
<lpage>1062</lpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>
<italic>ACE2</italic> and <italic>TMPRSS2</italic> Expression is Minimal in Isolated Human Islet α and β Cells.</title>
<p>(<bold>A</bold>) Relative expression of <italic>ACE2</italic> and <italic>TMPRSS2</italic> compared with select α (white bars) and β (green bars) cell type-enriched genes in sorted human islet α and β cells from previously published bulk RNA-seq datasets, reported as transcript per million mapped reads (TPM; n=7; (<xref ref-type="bibr" rid="R10">Blodgett et al., 2015</xref>)) or reads per kilobase of transcript per million mapped reads (RPKM; n=8; (<xref ref-type="bibr" rid="R5">Arda et al., 2016</xref>)). Mean expression values are presented as log<sub>2</sub> (TPM+1) or log<sub>2</sub> (RPKM+1) to account for negative values. Dotted line highlights <italic>ACE2</italic> and <italic>TMPRSS2</italic> expression. (<bold>B</bold>) Dot plots of <italic>ACE2</italic>, <italic>TMPRSS2</italic>, <italic>CTSL</italic>, <italic>ADAM17</italic>, <italic>FURIN</italic>, <italic>TMPRSS4</italic>, and <italic>DPP4</italic> expression compared with cell type-enriched genes from three single cell (sc) RNA-seq datasets (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>; <xref ref-type="bibr" rid="R35">Kaestner et al., 2019</xref>; <xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>). Dot size indicates percentage of cells in a given population expressing the gene; dot color represents scaled average expression. Dotted lines highlight expression of the putative SARS-CoV-2 entry machinery. Percentages of β cells expressing and co-expressing these genes are available in <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>. (<bold>C</bold>) Representative images showing an isolated islet from an adult human donor (top panels) and a pancreatic section from a juvenile human donor (bottom panels) stained for ACE2 (red; antibody ab15348), insulin (INS; green), glucagon (GCG; white), and DAPI (blue). Dotted yellow line denotes islet area. Scale bar is 50 μm. Human pancreatic donor information is available in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref> (1C, donors I1-I3, J1-J5). See also <xref ref-type="supplementary-material" rid="SD1">Figures S1, S2, and S4</xref>.</p>
</caption>
<graphic xlink:href="EMS94425-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>ACE2 and TMPRSS2 Protein are Not Detected in Human Islet α or β Cells in Adult Pancreas.</title>
<p>Immunostaining does not detect SARS-CoV-2 cell entry markers ACE2 (<bold>A</bold>, <bold>D</bold>, <bold>G</bold>, <bold>J</bold>, <bold>M</bold>, <bold>P</bold>; antibody AF933; in red) or TMPRSS2 (<bold>B</bold>, <bold>E</bold>, <bold>H</bold>, <bold>K</bold>, <bold>N</bold>, <bold>Q;</bold> in green), in islet β cells (INS, blue; <bold>C-C'</bold>, <bold>I-I'</bold>, <bold>O-O'</bold>) or islet α cells (GCG; blue; <bold>F-F'</bold>, <bold>L-L'</bold>, <bold>R-R'</bold>) in native pancreatic sections from adult donors without diabetes (<bold>A-F”</bold>) or from donors with type 2 (<bold>G-L”</bold>) or type 1 (<bold>M-R”</bold>) diabetes. Dotted yellow lines denote islets. Islet (i) and exocrine (e) inset areas are marked by yellow boxes in MERGE column with DAPI counterstain. Pancreatic ducts, identified structurally by rosette pattern of DAPI-labeled nuclei (white), are shown within dotted yellow lines in exocrine INSET column. Scale bars are 50 μm (<bold>A-R</bold>) and 25 μm (Insets, <bold>C'-R”</bold>). Human pancreatic donor information is available in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref> (<bold>A-F”</bold>, donor N9; <bold>G-L”</bold>, donor 2H; <bold>M-R”</bold>, donor 1C). See also <xref ref-type="supplementary-material" rid="SD1">Figures S2, S3, and S4</xref>.</p>
</caption>
<graphic xlink:href="EMS94425-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>ACE2 Protein is Localized to Islet and Exocrine Capillaries in Adult and Juvenile Human Pancreata.</title>
<p>Representative images of endothelial cells (CD31, white) and ACE2-positive perivascular cells (red; antibody ab15348) in the adult islet (<bold>A-D</bold>') and exocrine (<bold>E-H'</bold>) microvasculature, as well as in juvenile human islet (<bold>I-L'</bold>) microvasculature. Yellow arrowheads point to CD31-positive endothelial cells, while magenta arrowheads point to perivascular ACE2-positive cells. ACE2-positive perivascular cells abut the extracellular matrix marker collagen-IV within the vascular basement membrane (collagen-IV [COL4], green; <bold>D, D', H, H'</bold>). Inset areas (<bold>A'-L'</bold>) are marked by yellow boxes in <bold>A-L</bold>. In juvenile human pancreas (<bold>I-L'</bold>), ACE2 is not detected in islet endocrine cells expressing insulin and glucagon (ENDO, green); DAPI (blue). Scale bars are 50 μm (<bold>A-L</bold>) and 10 μm (Insets, <bold>A'-L'</bold>). Human pancreatic donor information is available in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref> (<bold>A-H'</bold>, donor N2; <bold>I-L'</bold>: donor J4). See also <xref ref-type="supplementary-material" rid="SD1">Figure S5</xref>.</p>
</caption>
<graphic xlink:href="EMS94425-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>ACE2 Protein is Expressed by Islet Pericytes.</title>
<p>(<bold>A-C</bold>) Maximum intensity projection of representative confocal images labelled for platelet-derived growth factor receptor β-positive cells (PDGFRβ, red) and ACE2 (green) in perivascular cells within a normal adult human islet; nuclear DAPI (blue). (<bold>D</bold>) Image of the same islet shown in A-C with insulin labeling (blue). Region within the yellow box in <bold>D</bold> is displayed in <bold>A-C</bold>. (<bold>E-G</bold>) Maximal intensity projection of pericyte labeling with an antibody against the pericyte marker neuron-glial antigen 2 (<bold>E</bold>, NG2, red) colocalized with ACE2 labeling (<bold>F</bold>, green) and nuclear DAPI (blue) in a normal adult human islet (<bold>E-F</bold>). (<bold>G</bold>) Image of the same islet shown in E-F with insulin labeling (blue). Regions within yellow boxes containing pericytes in <bold>G</bold> denote inset areas (<bold>G'</bold>) and represent a subset of islet ACE2-expressing pericytes. (<bold>H</bold>) Colocalization of ACE2 with NG2- or PDGFRβ-positive cells. (<bold>I</bold>) Quantification of ACE2-positive cells expressing pericyte markers NG2 and PDGFRβ. Shown are average values obtained for 3 confocal planes per islet for a minimum of 5 islets per each donor of a given age. Scale bars are 20 μm (<bold>A-C</bold>), 40 μm (<bold>D-G</bold>), and 10 μm (<bold>G'</bold>). Human pancreatic donor information is available in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref> (<bold>A-I,</bold> donors HP1754, HP2041, HP2091). See also <xref ref-type="supplementary-material" rid="SD1">Figure S5</xref>.</p>
</caption>
<graphic xlink:href="EMS94425-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>Analysis of ACE2 and TMPRSS2 Protein Expression in Pancreatic Ducts and Pancreatic Histology.</title>
<p>(<bold>A-D'</bold>) TMPRSS2 (green), but not ACE2 (red; antibody R&amp;D AF933), is expressed by KRT19-positive cells (blue) on the apical surface of intercalated and larger ducts throughout the exocrine compartment. DAPI (white). Yellow arrowheads point to TMPRSS2 on the apical surface of ductal cells (KRT19-positive). Magenta arrowheads point to ACE2-positive non-ductal cells. (<bold>E-H'</bold>) Rarely, both TMPRSS2 (green) and ACE2 (red; antibody R&amp;D AF933) were expressed on the apical surface of ductal epithelial cells (KRT19, blue), but appeared to be spatially distinct. Yellow and white arrowheads point to spatially distinct TMPRSS2 and ACE2 labeling, respectively, localized to the apical surface of larger ducts (KRT19-positive cells). Inset areas (<bold>A'-H'</bold>) are marked by yellow boxes in <bold>A-H</bold>. Scale bars are 50 μm (<bold>A-H</bold>) and 10 μm (<bold>A'-H'</bold>). (<bold>I</bold>), Representative H&amp;E image of human pancreas upon autopsy after COVID-19 disease. None of the seven donor samples evaluated showed signs of pancreatitis as determined by the histological absence of interstitial edema and inflammatory infiltrate, hemorrhage or necrosis. BV, blood vessel; D, duct. Scale bar in green is 100 μm. Human pancreatic donor information is available in <xref ref-type="supplementary-material" rid="SD1">Table S2</xref> (<bold>A-D'</bold>, donor N8; <bold>E-H'</bold>, donor N9; <bold>I</bold>, COVID-19 donor 1). See also <xref ref-type="supplementary-material" rid="SD1">Figure S3</xref>.</p>
</caption>
<graphic xlink:href="EMS94425-f005"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<caption>
<title>Key Resources Table</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" valign="top">REAGENT or RESOURCE</th>
<th align="left" valign="top">SOURCE</th>
<th align="left" valign="top">IDENTIFIER</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="3" align="left" valign="top">
<bold>Antibodies</bold>
</td>
</tr>
<tr>
<td align="left" valign="top">Mouse anti-Cytokeratin 19 (1:1000)</td>
<td align="left" valign="top">Abcam</td>
<td align="left" valign="top">Cat# ab194399</td>
</tr>
<tr>
<td align="left" valign="top">Rabbit anti-TMPRSS2 (1:400)</td>
<td align="left" valign="top">Sigma</td>
<td align="left" valign="top">Cat# HPA035787, RRID:AB_2674782</td>
</tr>
<tr>
<td align="left" valign="top">Mouse anti-Glucagon (1:500-1:1000)</td>
<td align="left" valign="top">Abcam</td>
<td align="left" valign="top">Cat# ab10988, RRID:AB_297642</td>
</tr>
<tr>
<td align="left" valign="top">Guinea pig anti-Glucagon (1:500)</td>
<td align="left" valign="top">LSBio</td>
<td align="left" valign="top">Cat# LS-C202759-50</td>
</tr>
<tr>
<td align="left" valign="top">Rat anti-C-peptide (1:1000)</td>
<td align="left" valign="top">DSHB</td>
<td align="left" valign="top">Cat# GN-ID4, RRID:AB_2255626</td>
</tr>
<tr>
<td align="left" valign="top">Guinea pig anti-Insulin (1:500-1:1000)</td>
<td align="left" valign="top">Dako</td>
<td align="left" valign="top">Cat# A0564, RRID:AB_2617169</td>
</tr>
<tr>
<td align="left" valign="top">Rabbit anti-ACE2 (1:500)</td>
<td align="left" valign="top">Atlas Antibodies</td>
<td align="left" valign="top">Cat# HPA000288, RRID:AB_1078160</td>
</tr>
<tr>
<td align="left" valign="top">Rabbit anti-ACE2 (1:1000)</td>
<td align="left" valign="top">Abcam</td>
<td align="left" valign="top">Cat# ab15348, RRID:AB_301861</td>
</tr>
<tr>
<td align="left" valign="top">Goat anti-ACE2 (1:200, <xref ref-type="supplementary-material" rid="SD1">Figure S1,3A-E;</xref> 1:400, <xref ref-type="fig" rid="F4">Figure 4</xref>)</td>
<td align="left" valign="top">R&amp;D</td>
<td align="left" valign="top">Cat# AF933, RRID:AB_355722</td>
</tr>
<tr>
<td align="left" valign="top">Mouse anti-ACE2 (1:33)</td>
<td align="left" valign="top">R&amp;D</td>
<td align="left" valign="top">Cat# MAB933, RRID:AB_2223153</td>
</tr>
<tr>
<td align="left" valign="top">Mouse anti-CD31 (1:50)</td>
<td align="left" valign="top">BD Biosciences</td>
<td align="left" valign="top">Cat# 550389, RRID:AB_2252087</td>
</tr>
<tr>
<td align="left" valign="top">Goat anti-collagen IV alpha 1 (1:500)</td>
<td align="left" valign="top">Novus</td>
<td align="left" valign="top">Cat# NBP1-26549, RRID:AB_1853202</td>
</tr>
<tr>
<td align="left" valign="top">Goat anti-DPP4 (1:200)</td>
<td align="left" valign="top">R&amp;D</td>
<td align="left" valign="top">Cat# AF1180, RRID:AB_354651</td>
</tr>
<tr>
<td align="left" valign="top">Mouse anti-NG2 [647] (1:50)</td>
<td align="left" valign="top">R&amp;D</td>
<td align="left" valign="top">Cat# FAB2585R;</td>
</tr>
<tr>
<td align="left" valign="top">Goat anti-PDGFRb (1:100)</td>
<td align="left" valign="top">R&amp;D</td>
<td align="left" valign="top">Cat# AF385, RRID:AB_355339</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-mouse-Cy2 (1:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 715-225-150, RRID:AB_2340826</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-mouse-Cy3 (1:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 715-165-150, RRID:AB_2340813</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-mouse-Cy5 (1:250 -1:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 715-175-151, RRID:AB_2340820</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-rabbit-Cy3 (1:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 711-165-152, RRID:AB_2307443</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-rat-Cy2 (1:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 712-225-153, RRID:AB_2340674</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-guinea pig-Cy2 (1:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 706-225-148, RRID:AB_2340467</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-goat-Cy2 (1:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 705-225-147, RRID:AB_2307341</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-goat-Cy3 (1:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 705-165-147, RRID:AB_2307351</td>
</tr>
<tr>
<td align="left" valign="top">Donkey anti-guinea pig-Cy5 (1:2501:500)</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 706-175-148, RRID:AB_2340462</td>
</tr>
<tr>
<td align="left" valign="top">Normal Donkey Serum</td>
<td align="left" valign="top">Jackson ImmunoResearch</td>
<td align="left" valign="top">Cat# 017-000-121, RRID: AB_2337258</td>
</tr>
<tr>
<td colspan="3" align="left" valign="top">
<bold>Bacterial and Virus Strains</bold>
</td>
</tr>
<tr>
<td align="left" valign="top">n/a</td>
<td align="left" valign="top"/>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top">
<bold>Biological Samples</bold>
</td>
<td align="left" valign="top"/>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top">Human pancreatic islets</td>
<td align="left" valign="top">Integrated Islet Distribution Program (IIDP)</td>
<td align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://iidp.coh.org">http://iidp.coh.org</ext-link>, RRID: SCR_014387</td>
</tr>
<tr>
<td align="left" valign="top">Human pancreatic tissue</td>
<td align="left" valign="top">International Institute for the Advancement of Medicine (IIAM)</td>
<td align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.iiam.org">http://www.iiam.org</ext-link>, RRID: SCR_016172</td>
</tr>
<tr>
<td align="left" valign="top">Human pancreatic tissue</td>
<td align="left" valign="top">National Disease Research Interchange (NDRI)</td>
<td align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://ndriresource.org">http://ndriresource.org</ext-link>, RRID: SCR_000550</td>
</tr>
<tr>
<td colspan="3" align="left" valign="top">
<bold>Chemicals, Peptides, and Recombinant Proteins</bold>
</td>
</tr>
<tr>
<td align="left" valign="top">Propidium Iodide</td>
<td align="left" valign="top">BD Biosciences</td>
<td align="left" valign="top">Cat# 556463</td>
</tr>
<tr>
<td align="left" valign="top">Antigen Unmasking Solution, Citrate-Based</td>
<td align="left" valign="top">Vector Laboratories</td>
<td align="left" valign="top">Cat# H-3300-250</td>
</tr>
<tr>
<td align="left" valign="top">1X PBS</td>
<td align="left" valign="top">Corning</td>
<td align="left" valign="top">Cat# 46-013-CM</td>
</tr>
<tr>
<td align="left" valign="top">Triton X-100</td>
<td align="left" valign="top">USB</td>
<td align="left" valign="top">Cat# 22686</td>
</tr>
<tr>
<td align="left" valign="top">BSA</td>
<td align="left" valign="top">Sigma</td>
<td align="left" valign="top">Cat# A6003-25G</td>
</tr>
<tr>
<td align="left" valign="top">Human ACE2 Peptide</td>
<td align="left" valign="top">Abcam</td>
<td align="left" valign="top">Cat# ab15352</td>
</tr>
<tr>
<td colspan="3" align="left" valign="top">
<bold>Critical Commercial Assays</bold>
</td>
</tr>
<tr>
<td align="left" valign="top">RNAqueous-Micro Kit</td>
<td align="left" valign="top">Fisher Scientific (Invitrogen)</td>
<td align="left" valign="top">Cat# AM1931</td>
</tr>
<tr>
<td align="left" valign="top">High Capacity cDNA Reverse Transcription Kit</td>
<td align="left" valign="top">Fisher Scientific (Invitrogen)</td>
<td align="left" valign="top">Cat# 4368814</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>Deposited Data</bold>
</td>
<td align="left" valign="top"/>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top">RNA-seq data for FACS purified human alpha and beta cells (<xref ref-type="bibr" rid="R10">Blodgett et al., 2015</xref>)</td>
<td align="left" valign="top">NCBI Gene Expression Omnibus</td>
<td align="left" valign="top">GEO: GSE67543</td>
</tr>
<tr>
<td align="left" valign="top">RNA-seq data for FACS purified human alpha and beta cells (<xref ref-type="bibr" rid="R5">Arda et al., 2016</xref>)</td>
<td align="left" valign="top">NCBI Gene Expression Omnibus</td>
<td align="left" valign="top">GEO: GSE57973</td>
</tr>
<tr>
<td align="left" valign="top">Single-cell RNA-seq data for human islets (<xref ref-type="bibr" rid="R8">Baron et al., 2016</xref>)</td>
<td align="left" valign="top">NCBI Gene Expression Omnibus</td>
<td align="left" valign="top">GEO: GSE84133</td>
</tr>
<tr>
<td align="left" valign="top">Single-cell RNA-seq data for human islets (<xref ref-type="bibr" rid="R18">Camunas-Soler et al., 2020</xref>)</td>
<td align="left" valign="top">NCBI Gene Expression Omnibus</td>
<td align="left" valign="top">GEO: GSE124742</td>
</tr>
<tr>
<td align="left" valign="top">Single-cell RNA-seq data for human islets (<xref ref-type="bibr" rid="R53">Segerstolpe et al., 2016</xref>)</td>
<td align="left" valign="top">ArrayExpress</td>
<td align="left" valign="top">E-MTAB-5061</td>
</tr>
<tr>
<td align="left" valign="top">Single-cell RNA-seq data for human islets (Human Pancreas Analysis Program [HPAP])</td>
<td align="left" valign="top">HPAP Database</td>
<td align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://hpap.pmacs.upenn.edu">https://hpap.pmacs.upenn.edu</ext-link> RRID:SCR_014393</td>
</tr>
<tr>
<td colspan="3" align="left" valign="top">
<bold>Experimental Models: Cell Lines</bold>
</td>
</tr>
<tr>
<td align="left" valign="top">n/a</td>
<td align="left" valign="top"/>
<td align="left" valign="top"/>
</tr>
<tr>
<td colspan="3" align="left" valign="top">
<bold>Experimental Models: Organisms/Strains</bold>
</td>
</tr>
<tr>
<td align="left" valign="top">n/a</td>
<td align="left" valign="top"/>
<td align="left" valign="top"/>
</tr>
<tr>
<td colspan="3" align="left" valign="top">
<bold>Recombinant DNA</bold>
</td>
</tr>
<tr>
<td align="left" valign="top">n/a</td>
<td align="left" valign="top"/>
<td align="left" valign="top"/>
</tr>
<tr>
<td colspan="3" align="left" valign="top">
<bold>Software and Algorithms</bold>
</td>
</tr>
<tr>
<td align="left" valign="top">FV31S-SW Viewer 2.4.1.198</td>
<td align="left" valign="top">Olympus</td>
<td align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://www.olympus-lifescience.com/en/support/downloads/">https://www.olympus-lifescience.com/en/support/downloads/</ext-link>
</td>
</tr>
<tr>
<td align="left" valign="top">Seurat 3.1 R package</td>
<td align="left" valign="top">(Butler et al., 2018) (<xref ref-type="bibr" rid="R56">Stuart et al., 2019</xref>)</td>
<td align="left" valign="top">N/A</td>
</tr>
<tr>
<td align="left" valign="top">Prism for macOS v.8.4.3</td>
<td align="left" valign="top">Graphpad Software</td>
<td align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com">http://www.graphpad.com</ext-link>, RRID: SCR_002798</td>
</tr>
<tr>
<td align="left" valign="top">JACoP: Just Another Co-localization Plugin</td>
<td align="left" valign="top">ImageJ</td>
<td align="left" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/plugins/track/jacop2.html">https://imagej.nih.gov/ij/plugins/track/jacop2.html</ext-link>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
